Pediatrix Medical Group Inc

For the period ended Dec 31, 2023. Filed Feb 20, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 20, 2024

MD$31.62+0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets at December 31, 2023 and 2022

(in thousands, except share data)

	December 31,
	2023	2022
ASSETS
Current assets:
Cash and cash equivalents	$73,258	$9,824
Short-term investments	104,485	93,239
Accounts receivable, net	272,313	296,787
Prepaid expenses	13,525	14,878
Income taxes receivable	7,565	—
Other current assets	12,308	13,261
Total current assets	483,454	427,989
Property and equipment, net	75,639	73,290
Goodwill	1,384,166	1,532,092
Intangible assets, net	21,240	18,491
Operating and finance lease right-of-use assets	70,294	66,924
Deferred income tax assets	102,852	105,925
Other assets	82,165	123,176
Total assets	$2,219,810	$2,347,887
LIABILITIES & SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses	$350,798	$374,225
Current portion of debt and finance lease liabilities, net	14,913	14,898
Current portion of operating lease liabilities	21,076	21,589
Income taxes payable	2,159	16,271
Total current liabilities	388,946	426,983
Line of credit	—	4,000
Long-term debt and finance lease liabilities, net	618,421	632,381
Long-term operating lease liabilities	47,238	44,213
Long-term professional liabilities	251,284	275,629
Deferred income tax liabilities	34,308	33,638
Other liabilities	30,552	39,411
Total liabilities	1,370,749	1,456,255
Commitments and contingencies
Shareholders’ equity:
Preferred stock; $.01 par value; 1,000,000 shares authorized; none issued	—	—
Common stock; $.01 par value; 200,000,000 shares authorized; 84,018,023 and 82,947,132 shares issued and outstanding, respectively	840	829
Additional paid-in capital	999,906	983,601
Accumulated other comprehensive loss	(2,214)	(3,735)
Retained deficit	(149,471)	(89,063)
Total shareholders’ equity	849,061	891,632
Total liabilities and shareholders' equity	$2,219,810	$2,347,887

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.